nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Rash generalised—Vemurafenib—melanoma	0.0374	0.0374	CcSEcCtD
Emtricitabine—Exfoliative rash—Docetaxel—melanoma	0.0312	0.0312	CcSEcCtD
Emtricitabine—Opportunistic infection—Temozolomide—melanoma	0.0202	0.0202	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Bleomycin—melanoma	0.0162	0.0162	CcSEcCtD
Emtricitabine—Rash maculo-papular—Vemurafenib—melanoma	0.0145	0.0145	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Carmustine—melanoma	0.0142	0.0142	CcSEcCtD
Emtricitabine—Rash generalised—Docetaxel—melanoma	0.0127	0.0127	CcSEcCtD
Emtricitabine—Hepatomegaly—Dactinomycin—melanoma	0.0127	0.0127	CcSEcCtD
Emtricitabine—Prurigo—Docetaxel—melanoma	0.0117	0.0117	CcSEcCtD
Emtricitabine—Myopathy—Temozolomide—melanoma	0.0116	0.0116	CcSEcCtD
Emtricitabine—Otitis media—Temozolomide—melanoma	0.0105	0.0105	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Docetaxel—melanoma	0.0091	0.0091	CcSEcCtD
Emtricitabine—Weight decreased—Vemurafenib—melanoma	0.00904	0.00904	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Temozolomide—melanoma	0.00895	0.00895	CcSEcCtD
Emtricitabine—Infestation NOS—Vemurafenib—melanoma	0.00891	0.00891	CcSEcCtD
Emtricitabine—Infestation—Vemurafenib—melanoma	0.00891	0.00891	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Vemurafenib—melanoma	0.00873	0.00873	CcSEcCtD
Emtricitabine—Neuropathy—Carmustine—melanoma	0.0079	0.0079	CcSEcCtD
Emtricitabine—Haemoglobin decreased—Docetaxel—melanoma	0.00786	0.00786	CcSEcCtD
Emtricitabine—Connective tissue disorder—Vemurafenib—melanoma	0.00786	0.00786	CcSEcCtD
Emtricitabine—Neuropathy—Temozolomide—melanoma	0.00764	0.00764	CcSEcCtD
Emtricitabine—Neuritis—Docetaxel—melanoma	0.00725	0.00725	CcSEcCtD
Emtricitabine—Mediastinal disorder—Vemurafenib—melanoma	0.0072	0.0072	CcSEcCtD
Emtricitabine—Malnutrition—Vemurafenib—melanoma	0.00696	0.00696	CcSEcCtD
Emtricitabine—Otitis media—Docetaxel—melanoma	0.00695	0.00695	CcSEcCtD
Emtricitabine—Back pain—Vemurafenib—melanoma	0.00673	0.00673	CcSEcCtD
Emtricitabine—Gastroenteritis—Temozolomide—melanoma	0.00666	0.00666	CcSEcCtD
Emtricitabine—Cough—Vemurafenib—melanoma	0.00607	0.00607	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Docetaxel—melanoma	0.00595	0.00595	CcSEcCtD
Emtricitabine—Arthralgia—Vemurafenib—melanoma	0.00592	0.00592	CcSEcCtD
Emtricitabine—Myalgia—Vemurafenib—melanoma	0.00592	0.00592	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00588	0.00588	CcSEcCtD
Emtricitabine—Bone pain—Docetaxel—melanoma	0.00565	0.00565	CcSEcCtD
Emtricitabine—Infection—Vemurafenib—melanoma	0.00564	0.00564	CcSEcCtD
Emtricitabine—Inflammation—Docetaxel—melanoma	0.00558	0.00558	CcSEcCtD
Emtricitabine—Nervous system disorder—Vemurafenib—melanoma	0.00557	0.00557	CcSEcCtD
Emtricitabine—Hypokalaemia—Carmustine—melanoma	0.00556	0.00556	CcSEcCtD
Emtricitabine—Skin disorder—Vemurafenib—melanoma	0.00552	0.00552	CcSEcCtD
Emtricitabine—Weight decreased—Bleomycin—melanoma	0.00547	0.00547	CcSEcCtD
Emtricitabine—Pneumonia—Bleomycin—melanoma	0.00543	0.00543	CcSEcCtD
Emtricitabine—Muscular weakness—Carmustine—melanoma	0.00539	0.00539	CcSEcCtD
Emtricitabine—Hypokalaemia—Temozolomide—melanoma	0.00537	0.00537	CcSEcCtD
Emtricitabine—Breast disorder—Temozolomide—melanoma	0.00534	0.00534	CcSEcCtD
Emtricitabine—Neutropenia—Dactinomycin—melanoma	0.00528	0.00528	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Temozolomide—melanoma	0.00521	0.00521	CcSEcCtD
Emtricitabine—Muscular weakness—Temozolomide—melanoma	0.00521	0.00521	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00517	0.00517	CcSEcCtD
Emtricitabine—Haematuria—Bleomycin—melanoma	0.00514	0.00514	CcSEcCtD
Emtricitabine—Neuropathy—Docetaxel—melanoma	0.00508	0.00508	CcSEcCtD
Emtricitabine—Pneumonia—Dactinomycin—melanoma	0.00506	0.00506	CcSEcCtD
Emtricitabine—Neutropenia—Carmustine—melanoma	0.00494	0.00494	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Vemurafenib—melanoma	0.0049	0.0049	CcSEcCtD
Emtricitabine—Fatigue—Vemurafenib—melanoma	0.0049	0.0049	CcSEcCtD
Emtricitabine—Neutropenia—Temozolomide—melanoma	0.00477	0.00477	CcSEcCtD
Emtricitabine—Hyperglycaemia—Carmustine—melanoma	0.00476	0.00476	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Temozolomide—melanoma	0.00474	0.00474	CcSEcCtD
Emtricitabine—Pneumonia—Carmustine—melanoma	0.00474	0.00474	CcSEcCtD
Emtricitabine—Depression—Carmustine—melanoma	0.0047	0.0047	CcSEcCtD
Emtricitabine—Renal failure—Carmustine—melanoma	0.00463	0.00463	CcSEcCtD
Emtricitabine—Weight decreased—Temozolomide—melanoma	0.00462	0.00462	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Carmustine—melanoma	0.00462	0.00462	CcSEcCtD
Emtricitabine—Hyperglycaemia—Temozolomide—melanoma	0.0046	0.0046	CcSEcCtD
Emtricitabine—Urinary tract infection—Carmustine—melanoma	0.00458	0.00458	CcSEcCtD
Emtricitabine—Pneumonia—Temozolomide—melanoma	0.00458	0.00458	CcSEcCtD
Emtricitabine—Infestation NOS—Temozolomide—melanoma	0.00455	0.00455	CcSEcCtD
Emtricitabine—Infestation—Temozolomide—melanoma	0.00455	0.00455	CcSEcCtD
Emtricitabine—Depression—Temozolomide—melanoma	0.00454	0.00454	CcSEcCtD
Emtricitabine—Hepatitis—Dactinomycin—melanoma	0.00452	0.00452	CcSEcCtD
Emtricitabine—Body temperature increased—Vemurafenib—melanoma	0.00449	0.00449	CcSEcCtD
Emtricitabine—Pharyngitis—Dactinomycin—melanoma	0.00448	0.00448	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Temozolomide—melanoma	0.00446	0.00446	CcSEcCtD
Emtricitabine—Urinary tract infection—Temozolomide—melanoma	0.00442	0.00442	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Temozolomide—melanoma	0.0043	0.0043	CcSEcCtD
Emtricitabine—Sinusitis—Temozolomide—melanoma	0.00427	0.00427	CcSEcCtD
Emtricitabine—Hypersensitivity—Vemurafenib—melanoma	0.00418	0.00418	CcSEcCtD
Emtricitabine—Connective tissue disorder—Carmustine—melanoma	0.00415	0.00415	CcSEcCtD
Emtricitabine—Renal impairment—Docetaxel—melanoma	0.00413	0.00413	CcSEcCtD
Emtricitabine—Dermatitis bullous—Docetaxel—melanoma	0.00411	0.00411	CcSEcCtD
Emtricitabine—Hepatitis—Temozolomide—melanoma	0.00409	0.00409	CcSEcCtD
Emtricitabine—Asthenia—Vemurafenib—melanoma	0.00407	0.00407	CcSEcCtD
Emtricitabine—Pharyngitis—Temozolomide—melanoma	0.00405	0.00405	CcSEcCtD
Emtricitabine—Urinary tract disorder—Temozolomide—melanoma	0.00403	0.00403	CcSEcCtD
Emtricitabine—Pruritus—Vemurafenib—melanoma	0.00402	0.00402	CcSEcCtD
Emtricitabine—Connective tissue disorder—Temozolomide—melanoma	0.00401	0.00401	CcSEcCtD
Emtricitabine—Urethral disorder—Temozolomide—melanoma	0.004	0.004	CcSEcCtD
Emtricitabine—Anaemia—Bleomycin—melanoma	0.0039	0.0039	CcSEcCtD
Emtricitabine—Diarrhoea—Vemurafenib—melanoma	0.00389	0.00389	CcSEcCtD
Emtricitabine—Dizziness—Vemurafenib—melanoma	0.00376	0.00376	CcSEcCtD
Emtricitabine—Mental disorder—Carmustine—melanoma	0.0037	0.0037	CcSEcCtD
Emtricitabine—Immune system disorder—Temozolomide—melanoma	0.00369	0.00369	CcSEcCtD
Emtricitabine—Mediastinal disorder—Temozolomide—melanoma	0.00368	0.00368	CcSEcCtD
Emtricitabine—Malnutrition—Carmustine—melanoma	0.00368	0.00368	CcSEcCtD
Emtricitabine—Cough—Bleomycin—melanoma	0.00368	0.00368	CcSEcCtD
Emtricitabine—Anaemia—Dactinomycin—melanoma	0.00363	0.00363	CcSEcCtD
Emtricitabine—Vomiting—Vemurafenib—melanoma	0.00361	0.00361	CcSEcCtD
Emtricitabine—Myalgia—Bleomycin—melanoma	0.00359	0.00359	CcSEcCtD
Emtricitabine—Rash—Vemurafenib—melanoma	0.00358	0.00358	CcSEcCtD
Emtricitabine—Mental disorder—Temozolomide—melanoma	0.00358	0.00358	CcSEcCtD
Emtricitabine—Dermatitis—Vemurafenib—melanoma	0.00358	0.00358	CcSEcCtD
Emtricitabine—Back pain—Carmustine—melanoma	0.00356	0.00356	CcSEcCtD
Emtricitabine—Headache—Vemurafenib—melanoma	0.00356	0.00356	CcSEcCtD
Emtricitabine—Malnutrition—Temozolomide—melanoma	0.00356	0.00356	CcSEcCtD
Emtricitabine—Breast disorder—Docetaxel—melanoma	0.00355	0.00355	CcSEcCtD
Emtricitabine—Nasopharyngitis—Docetaxel—melanoma	0.00351	0.00351	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Docetaxel—melanoma	0.00346	0.00346	CcSEcCtD
Emtricitabine—Back pain—Temozolomide—melanoma	0.00344	0.00344	CcSEcCtD
Emtricitabine—Infection—Bleomycin—melanoma	0.00342	0.00342	CcSEcCtD
Emtricitabine—Anaemia—Carmustine—melanoma	0.0034	0.0034	CcSEcCtD
Emtricitabine—Nausea—Vemurafenib—melanoma	0.00337	0.00337	CcSEcCtD
Emtricitabine—Thrombocytopenia—Bleomycin—melanoma	0.00337	0.00337	CcSEcCtD
Emtricitabine—Myalgia—Dactinomycin—melanoma	0.00335	0.00335	CcSEcCtD
Emtricitabine—Anaemia—Temozolomide—melanoma	0.00329	0.00329	CcSEcCtD
Emtricitabine—Angioedema—Temozolomide—melanoma	0.00325	0.00325	CcSEcCtD
Emtricitabine—Infection—Dactinomycin—melanoma	0.00319	0.00319	CcSEcCtD
Emtricitabine—Neutropenia—Docetaxel—melanoma	0.00317	0.00317	CcSEcCtD
Emtricitabine—Thrombocytopenia—Dactinomycin—melanoma	0.00314	0.00314	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00314	0.00314	CcSEcCtD
Emtricitabine—Myalgia—Carmustine—melanoma	0.00313	0.00313	CcSEcCtD
Emtricitabine—Anxiety—Carmustine—melanoma	0.00312	0.00312	CcSEcCtD
Emtricitabine—Cough—Temozolomide—melanoma	0.0031	0.0031	CcSEcCtD
Emtricitabine—Paraesthesia—Bleomycin—melanoma	0.00309	0.00309	CcSEcCtD
Emtricitabine—Weight decreased—Docetaxel—melanoma	0.00307	0.00307	CcSEcCtD
Emtricitabine—Dyspnoea—Bleomycin—melanoma	0.00307	0.00307	CcSEcCtD
Emtricitabine—Pneumonia—Docetaxel—melanoma	0.00304	0.00304	CcSEcCtD
Emtricitabine—Myalgia—Temozolomide—melanoma	0.00303	0.00303	CcSEcCtD
Emtricitabine—Arthralgia—Temozolomide—melanoma	0.00303	0.00303	CcSEcCtD
Emtricitabine—Infestation—Docetaxel—melanoma	0.00303	0.00303	CcSEcCtD
Emtricitabine—Infestation NOS—Docetaxel—melanoma	0.00303	0.00303	CcSEcCtD
Emtricitabine—Anxiety—Temozolomide—melanoma	0.00302	0.00302	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00301	0.00301	CcSEcCtD
Emtricitabine—Infection—Carmustine—melanoma	0.00298	0.00298	CcSEcCtD
Emtricitabine—Renal failure—Docetaxel—melanoma	0.00298	0.00298	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Docetaxel—melanoma	0.00297	0.00297	CcSEcCtD
Emtricitabine—Pain—Bleomycin—melanoma	0.00294	0.00294	CcSEcCtD
Emtricitabine—Thrombocytopenia—Carmustine—melanoma	0.00294	0.00294	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00292	0.00292	CcSEcCtD
Emtricitabine—Infection—Temozolomide—melanoma	0.00288	0.00288	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Docetaxel—melanoma	0.00286	0.00286	CcSEcCtD
Emtricitabine—Nervous system disorder—Temozolomide—melanoma	0.00285	0.00285	CcSEcCtD
Emtricitabine—Thrombocytopenia—Temozolomide—melanoma	0.00284	0.00284	CcSEcCtD
Emtricitabine—Skin disorder—Temozolomide—melanoma	0.00282	0.00282	CcSEcCtD
Emtricitabine—Fatigue—Dactinomycin—melanoma	0.00277	0.00277	CcSEcCtD
Emtricitabine—Pain—Dactinomycin—melanoma	0.00274	0.00274	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Carmustine—melanoma	0.00274	0.00274	CcSEcCtD
Emtricitabine—Urticaria—Bleomycin—melanoma	0.00273	0.00273	CcSEcCtD
Emtricitabine—Rhinitis—Docetaxel—melanoma	0.00272	0.00272	CcSEcCtD
Emtricitabine—Body temperature increased—Bleomycin—melanoma	0.00272	0.00272	CcSEcCtD
Emtricitabine—Hepatitis—Docetaxel—melanoma	0.00272	0.00272	CcSEcCtD
Emtricitabine—Insomnia—Carmustine—melanoma	0.00272	0.00272	CcSEcCtD
Emtricitabine—Paraesthesia—Carmustine—melanoma	0.0027	0.0027	CcSEcCtD
Emtricitabine—Pharyngitis—Docetaxel—melanoma	0.0027	0.0027	CcSEcCtD
Emtricitabine—Urinary tract disorder—Docetaxel—melanoma	0.00268	0.00268	CcSEcCtD
Emtricitabine—Dyspnoea—Carmustine—melanoma	0.00268	0.00268	CcSEcCtD
Emtricitabine—Connective tissue disorder—Docetaxel—melanoma	0.00267	0.00267	CcSEcCtD
Emtricitabine—Urethral disorder—Docetaxel—melanoma	0.00266	0.00266	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00264	0.00264	CcSEcCtD
Emtricitabine—Insomnia—Temozolomide—melanoma	0.00263	0.00263	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Dactinomycin—melanoma	0.00262	0.00262	CcSEcCtD
Emtricitabine—Paraesthesia—Temozolomide—melanoma	0.00261	0.00261	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Carmustine—melanoma	0.00259	0.00259	CcSEcCtD
Emtricitabine—Dyspnoea—Temozolomide—melanoma	0.00259	0.00259	CcSEcCtD
Emtricitabine—Pain—Carmustine—melanoma	0.00257	0.00257	CcSEcCtD
Emtricitabine—Dyspepsia—Temozolomide—melanoma	0.00256	0.00256	CcSEcCtD
Emtricitabine—Abdominal pain—Dactinomycin—melanoma	0.00254	0.00254	CcSEcCtD
Emtricitabine—Body temperature increased—Dactinomycin—melanoma	0.00254	0.00254	CcSEcCtD
Emtricitabine—Hypersensitivity—Bleomycin—melanoma	0.00254	0.00254	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Temozolomide—melanoma	0.00251	0.00251	CcSEcCtD
Emtricitabine—Fatigue—Temozolomide—melanoma	0.0025	0.0025	CcSEcCtD
Emtricitabine—Pain—Temozolomide—melanoma	0.00248	0.00248	CcSEcCtD
Emtricitabine—Asthenia—Bleomycin—melanoma	0.00247	0.00247	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Carmustine—melanoma	0.00246	0.00246	CcSEcCtD
Emtricitabine—Immune system disorder—Docetaxel—melanoma	0.00245	0.00245	CcSEcCtD
Emtricitabine—Mediastinal disorder—Docetaxel—melanoma	0.00245	0.00245	CcSEcCtD
Emtricitabine—Pruritus—Bleomycin—melanoma	0.00243	0.00243	CcSEcCtD
Emtricitabine—Mental disorder—Docetaxel—melanoma	0.00238	0.00238	CcSEcCtD
Emtricitabine—Abdominal pain—Carmustine—melanoma	0.00237	0.00237	CcSEcCtD
Emtricitabine—Body temperature increased—Carmustine—melanoma	0.00237	0.00237	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Temozolomide—melanoma	0.00237	0.00237	CcSEcCtD
Emtricitabine—Malnutrition—Docetaxel—melanoma	0.00237	0.00237	CcSEcCtD
Emtricitabine—Hypersensitivity—Dactinomycin—melanoma	0.00236	0.00236	CcSEcCtD
Emtricitabine—Urticaria—Temozolomide—melanoma	0.00231	0.00231	CcSEcCtD
Emtricitabine—Asthenia—Dactinomycin—melanoma	0.0023	0.0023	CcSEcCtD
Emtricitabine—Abdominal pain—Temozolomide—melanoma	0.00229	0.00229	CcSEcCtD
Emtricitabine—Body temperature increased—Temozolomide—melanoma	0.00229	0.00229	CcSEcCtD
Emtricitabine—Back pain—Docetaxel—melanoma	0.00229	0.00229	CcSEcCtD
Emtricitabine—Hypersensitivity—Carmustine—melanoma	0.00221	0.00221	CcSEcCtD
Emtricitabine—Diarrhoea—Dactinomycin—melanoma	0.0022	0.0022	CcSEcCtD
Emtricitabine—Vomiting—Bleomycin—melanoma	0.00219	0.00219	CcSEcCtD
Emtricitabine—Anaemia—Docetaxel—melanoma	0.00219	0.00219	CcSEcCtD
Emtricitabine—Rash—Bleomycin—melanoma	0.00217	0.00217	CcSEcCtD
Emtricitabine—Dermatitis—Bleomycin—melanoma	0.00217	0.00217	CcSEcCtD
Emtricitabine—Asthenia—Carmustine—melanoma	0.00216	0.00216	CcSEcCtD
Emtricitabine—Hypersensitivity—Temozolomide—melanoma	0.00214	0.00214	CcSEcCtD
Emtricitabine—Asthenia—Temozolomide—melanoma	0.00208	0.00208	CcSEcCtD
Emtricitabine—Cough—Docetaxel—melanoma	0.00206	0.00206	CcSEcCtD
Emtricitabine—Diarrhoea—Carmustine—melanoma	0.00206	0.00206	CcSEcCtD
Emtricitabine—Pruritus—Temozolomide—melanoma	0.00205	0.00205	CcSEcCtD
Emtricitabine—Nausea—Bleomycin—melanoma	0.00204	0.00204	CcSEcCtD
Emtricitabine—Vomiting—Dactinomycin—melanoma	0.00204	0.00204	CcSEcCtD
Emtricitabine—Rash—Dactinomycin—melanoma	0.00202	0.00202	CcSEcCtD
Emtricitabine—Myalgia—Docetaxel—melanoma	0.00201	0.00201	CcSEcCtD
Emtricitabine—Arthralgia—Docetaxel—melanoma	0.00201	0.00201	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.002	0.002	CcSEcCtD
Emtricitabine—Dizziness—Carmustine—melanoma	0.00199	0.00199	CcSEcCtD
Emtricitabine—Diarrhoea—Temozolomide—melanoma	0.00199	0.00199	CcSEcCtD
Emtricitabine—Dizziness—Temozolomide—melanoma	0.00192	0.00192	CcSEcCtD
Emtricitabine—Infection—Docetaxel—melanoma	0.00192	0.00192	CcSEcCtD
Emtricitabine—Vomiting—Carmustine—melanoma	0.00191	0.00191	CcSEcCtD
Emtricitabine—Nausea—Dactinomycin—melanoma	0.00191	0.00191	CcSEcCtD
Emtricitabine—Rash—Carmustine—melanoma	0.00189	0.00189	CcSEcCtD
Emtricitabine—Nervous system disorder—Docetaxel—melanoma	0.00189	0.00189	CcSEcCtD
Emtricitabine—Dermatitis—Carmustine—melanoma	0.00189	0.00189	CcSEcCtD
Emtricitabine—Thrombocytopenia—Docetaxel—melanoma	0.00189	0.00189	CcSEcCtD
Emtricitabine—Headache—Carmustine—melanoma	0.00188	0.00188	CcSEcCtD
Emtricitabine—Skin disorder—Docetaxel—melanoma	0.00187	0.00187	CcSEcCtD
Emtricitabine—Vomiting—Temozolomide—melanoma	0.00185	0.00185	CcSEcCtD
Emtricitabine—Rash—Temozolomide—melanoma	0.00183	0.00183	CcSEcCtD
Emtricitabine—Dermatitis—Temozolomide—melanoma	0.00183	0.00183	CcSEcCtD
Emtricitabine—Headache—Temozolomide—melanoma	0.00182	0.00182	CcSEcCtD
Emtricitabine—Nausea—Carmustine—melanoma	0.00178	0.00178	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00176	0.00176	CcSEcCtD
Emtricitabine—Insomnia—Docetaxel—melanoma	0.00175	0.00175	CcSEcCtD
Emtricitabine—Paraesthesia—Docetaxel—melanoma	0.00173	0.00173	CcSEcCtD
Emtricitabine—Nausea—Temozolomide—melanoma	0.00172	0.00172	CcSEcCtD
Emtricitabine—Dyspnoea—Docetaxel—melanoma	0.00172	0.00172	CcSEcCtD
Emtricitabine—Dyspepsia—Docetaxel—melanoma	0.0017	0.0017	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Docetaxel—melanoma	0.00167	0.00167	CcSEcCtD
Emtricitabine—Fatigue—Docetaxel—melanoma	0.00166	0.00166	CcSEcCtD
Emtricitabine—Pain—Docetaxel—melanoma	0.00165	0.00165	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Docetaxel—melanoma	0.00158	0.00158	CcSEcCtD
Emtricitabine—Abdominal pain—Docetaxel—melanoma	0.00153	0.00153	CcSEcCtD
Emtricitabine—Body temperature increased—Docetaxel—melanoma	0.00153	0.00153	CcSEcCtD
Emtricitabine—Hypersensitivity—Docetaxel—melanoma	0.00142	0.00142	CcSEcCtD
Emtricitabine—Asthenia—Docetaxel—melanoma	0.00138	0.00138	CcSEcCtD
Emtricitabine—Pruritus—Docetaxel—melanoma	0.00137	0.00137	CcSEcCtD
Emtricitabine—Diarrhoea—Docetaxel—melanoma	0.00132	0.00132	CcSEcCtD
Emtricitabine—Dizziness—Docetaxel—melanoma	0.00128	0.00128	CcSEcCtD
Emtricitabine—Vomiting—Docetaxel—melanoma	0.00123	0.00123	CcSEcCtD
Emtricitabine—Rash—Docetaxel—melanoma	0.00122	0.00122	CcSEcCtD
Emtricitabine—Dermatitis—Docetaxel—melanoma	0.00122	0.00122	CcSEcCtD
Emtricitabine—Headache—Docetaxel—melanoma	0.00121	0.00121	CcSEcCtD
Emtricitabine—Nausea—Docetaxel—melanoma	0.00115	0.00115	CcSEcCtD
